New treatments for COVID-19 using nitazoxanide and ivermectin
Nitazoxanide in Treatment of COVID-19
This study is testing if the medications nitazoxanide and ivermectin, alone or with other drugs, can help people with COVID-19 feel better.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 2 sites (Tanta and 1 other locations) |
| Trial ID | NCT04382846 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of nitazoxanide and ivermectin in treating COVID-19. It aims to evaluate the clinical efficacy of these medications, both individually and in combination with other drugs like azithromycin and chloroquine. The study is designed as a Phase 3 interventional trial, focusing on patients diagnosed with COVID-19. By assessing various treatment regimens, the trial seeks to identify the most effective approach to combat this viral infection.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with COVID-19 infection.
Not a fit: Patients with allergies or contraindications to the study drugs will not benefit from this trial.
Why it matters
Potential benefit: If successful, this trial could lead to improved treatment options for patients suffering from COVID-19.
How similar studies have performed: Other studies have shown promising results with similar treatment approaches, suggesting potential efficacy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with COVID-19 infection Exclusion Criteria: * Allergy or contraindication to the drugs.
Where this trial is running
Tanta and 1 other locations
- Tanta University, Assiut University — Tanta, Egypt (Recruiting)
- Sherief Abd-Elsalam — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: sherief Abd-Elsalam, Ass. Prof. — ass. Prof. Tropical Medicine
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.